BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31139968)

  • 1. Nanostructured Lipid Carrier of Propofol: a Promising Alternative to Marketed Soybean Oil-Based Nanoemulsion.
    Shevalkar G; Pai R; Vavia P
    AAPS PharmSciTech; 2019 May; 20(5):201. PubMed ID: 31139968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and evaluation of microemulsions for improved parenteral delivery of propofol.
    Date AA; Nagarsenker MS
    AAPS PharmSciTech; 2008; 9(1):138-45. PubMed ID: 18446474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication and characterization of nanostructured lipid carriers (NLC) using a plant-based emulsifier: Quillaja saponin.
    Kharat M; McClements DJ
    Food Res Int; 2019 Dec; 126():108601. PubMed ID: 31732055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
    Kaur N; Sharma K; Bedi N
    Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured lipid carriers for the topical delivery of tretinoin.
    Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
    Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel, lipid-free nanodispersion formulation of propofol and its characterization.
    Chen H; Zhang Z; Almarsson O; Marier JF; Berkovitz D; Gardner CR
    Pharm Res; 2005 Mar; 22(3):356-61. PubMed ID: 15835740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
    Gadhave DG; Tagalpallewar AA; Kokare CR
    AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
    Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
    Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Activity of Nanostructured Lipid Carriers Loaded
    Fathi N; Lotfipour F; Dizaj SM; Hamishehkar H; Mohammadi M
    Pharm Nanotechnol; 2020; 8(6):485-494. PubMed ID: 33407060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy.
    Ferreira M; Chaves LL; Lima SA; Reis S
    Int J Pharm; 2015 Aug; 492(1-2):65-72. PubMed ID: 26169145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and characterization of novel nanostructured lipid carriers made from beeswax, propolis wax and pomegranate seed oil.
    Soleimanian Y; Goli SAH; Varshosaz J; Sahafi SM
    Food Chem; 2018 Apr; 244():83-92. PubMed ID: 29120809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carriers as a delivery system of biochanin A.
    Wang Q; Cheng H; Zhou K; Wang L; Dong S; Wang D; Chen W
    Drug Deliv; 2013 Nov; 20(8):331-7. PubMed ID: 24111887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Pharmacokinetic Activity of Zotepine via Nanostructured Lipid Carrier System in Wistar Rats for Oral Application.
    Tirumalesh C; Suram D; Dudhipala N; Banala N
    Pharm Nanotechnol; 2020; 8(2):148-160. PubMed ID: 32096755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers.
    Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X
    AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.